Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumedic is a healthcare technology company that utilizes blockchain and distributed ledger technology to modernize revenue cycle management and health data exchange. Founded in 2018 and subsequently acquired by Providence, the company focuses on reducing administrative waste by automating interactions between healthcare providers and insurers, such as prior authorizations. Lumedic also played a pivotal role in the development of digital health credentials, providing a platform for secure, verifiable COVID-19 vaccination records. Their technology emphasizes patient-centric data ownership and interoperability using industry standards like HL7 FHIR. By streamlining the financial clearance process, Lumedic aims to lower costs and improve the speed of care delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumedic.